Mandl József, Medve László, Temesi Alfreda, Vizi E Szilveszter
Orv Hetil. 2003 Jan 12;144(2):73-6.
Hungary joined the Ovideo Treaty (a bioethical health agreement signed by EU countries in 1997), as declared by Law Nr. VI in 2002. In July 1 2002 two departmental orders were enacted: departmental order Nr. [23/2002 (V. 9.)] about the biomedical research in humans and departmental order Nr. [24/2002 (V. 9.)] about the human use and clinical trials of investigational products and the adaptation of Good Clinical Practice (GCP). Both were based on the Health Law. The departmental order on the Medical Research Council [(16/2001 (IV. 28.)] together with these two orders contains the national rules of biomedical research performed in Hungary and also the Hungarian adaptation of various, bioethical principles and directives published by EU or other internationally accepted organisations. According to these regulations from 2002 biomedical research in Hungary could be in agreement with the Oviedo Treaty. Ethical approval and supervision can be obtained from research ethical committees of three types: central, regional and local superimposed upon one another. There are three, central, ethical committees within the frames of the Medical Research Council with national responsibility: Scientific and Research Ethical Committee, Clinical Pharmacological Ethical Committee, Human Reproduction Committee. In some cases regional research ethical committees are entitled to hand out ethical approval and ethical supervision. In those research sites, where the regional research ethical committee is not existent a local committee should be organized for the local ethical control of the research investigations and experiments. This way the ethical requirements and clinical practice by the GCP can be performed in clinical research in Hungary with a special respect to the vulnerable persons possibly involved. The paper gives an overview on recent developments and major ethical principles of the Hungarian biomedical research.
匈牙利于2002年通过第VI号法律宣布加入《奥维耶多公约》(一项欧盟国家于1997年签署的生物伦理健康协议)。2002年7月1日颁布了两项部门命令:关于人体生物医学研究的第[23/2002 (V. 9.)]号部门命令以及关于研究用产品的人体使用和临床试验及《药品临床试验管理规范》(GCP)适用的第[24/2002 (V. 9.)]号部门命令。两者均以《健康法》为依据。关于医学研究委员会的第[(16/2001 (IV. 28.)]号部门命令与这两项命令共同包含了匈牙利进行生物医学研究的国家规则,以及匈牙利对欧盟或其他国际认可组织发布的各种生物伦理原则和指令的适用。根据这些2002年的规定,匈牙利的生物医学研究可以符合《奥维耶多公约》。伦理批准和监督可从三种类型的研究伦理委员会获得:中央、地区和地方伦理委员会,它们相互叠加。在医学研究委员会框架内有三个负责全国事务的中央伦理委员会:科学与研究伦理委员会、临床药理伦理委员会、人类生殖委员会。在某些情况下,地区研究伦理委员会有权给予伦理批准和进行伦理监督。在那些不存在地区研究伦理委员会的研究地点,应组建一个地方委员会,对研究调查和实验进行地方伦理控制。这样,在匈牙利的临床研究中就能特别尊重可能涉及的弱势群体,执行GCP的伦理要求和临床实践。本文概述了匈牙利生物医学研究的最新发展和主要伦理原则。